Coronavirus Vaccines

A new health study has claimed that the antibodies produced in response to the vaccines are less effective against the new COVID-19 strains. Published in the journal of Nature Medicine, the study explained that new COVID-19 variants reported in UK, South Africa and Brazil have the ability to evade antibodies. Besides, the Washington University of Medicine scientists have also emphasised on the need of producing purified antibodies to… read-more

The Centre on March 1 stated CoWIN app has been developed only for administrators to manage the inoculation drive and is not a registration platform for COVID-19 vaccination. It clarified that individuals, who want to get vaccinated, can register themselves through official website. The statement followed the beginning of India's second-phase of mass vaccination which is expected to cover around 27 crore people who are either aged above 60 or… read-more

Addressing the rumours regarding COVID -19 vaccine, the Union Home Secretary Ajay Bhalla asked the states to counter the spread of false information.  He said, "vested interests can create unwanted doubts among people at large" and that needs to be curbed. Besides, the letter provisioned penal actions under the Disaster Management Act and IPC for the culprits. Earlier, the health ministry had released posters to tackle the vaccine hesitancy… read-more

Delhi CM Arvind Kejriwal has stated that COVID-19 vaccinations would begin on January 16 in the national capital. Reportedly, the vaccination drive will be held four days a week - Monday, Tuesday, Thursday, and Saturday - at 81 centres initially and will be increased subsequently. CM Kejriwal added, “Everyday almost 100 people will be vaccinated.” Besides, the government plans to inoculate 8,100 healthcare workers on the first day.

Ending the wait for COVID-19 vaccine, VG Somani, the Drug Controller General of India, on January 3 granted emergency-use approval to 'Covaxin' and 'Covishield'. Assuring people about the efficacy, Somani said, “We'll never approve anything if there is slightest of safety concern.” Moreover, the DCGI approved the vaccines for their "restricted use" based on the data submitted by Bharat Biotech and the Serum Institute of India. PM Narendra… read-more